Olga Rios

1.4k total citations · 1 hit paper
27 papers, 892 citations indexed

About

Olga Rios is a scholar working on Hematology, Immunology and Cancer Research. According to data from OpenAlex, Olga Rios has authored 27 papers receiving a total of 892 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 7 papers in Immunology and 6 papers in Cancer Research. Recurrent topics in Olga Rios's work include Hematopoietic Stem Cell Transplantation (21 papers), Acute Myeloid Leukemia Research (6 papers) and Platelet Disorders and Treatments (5 papers). Olga Rios is often cited by papers focused on Hematopoietic Stem Cell Transplantation (21 papers), Acute Myeloid Leukemia Research (6 papers) and Platelet Disorders and Treatments (5 papers). Olga Rios collaborates with scholars based in United States, Brazil and Switzerland. Olga Rios's co-authors include Neal S. Young, Colin O. Wu, Phillip Scheinberg, Xingmin Feng, Barbara Weinstein, Jennifer Lotter, Danielle M. Townsley, Bogdan Dumitriu, Marie J. Desierto and Cynthia E. Dunbar and has published in prestigious journals such as New England Journal of Medicine, Blood and British Journal of Haematology.

In The Last Decade

Olga Rios

26 papers receiving 881 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia

2017 337 citations Danielle M. Townsley, Phillip Scheinberg et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Olga Rios

Since Specialization

Citations

This map shows the geographic impact of Olga Rios's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olga Rios with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olga Rios more than expected).

Fields of papers citing papers by Olga Rios

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olga Rios. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olga Rios. The network helps show where Olga Rios may publish in the future.

Co-authorship network of co-authors of Olga Rios

This figure shows the co-authorship network connecting the top 25 collaborators of Olga Rios. A scholar is included among the top collaborators of Olga Rios based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olga Rios. Olga Rios is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Longitudinal Contribution of Distinct Hematopoietic Clones during Marrow Recovery in Immune Aplastic Anemia 2024 ·Blood ·Fernanda Gutierrez‐Rodrigues, Emma M. Groarke, Lemlem Alemu, Olga Rios, Diego Quinones Raffo, Jennifer Lotter, Neal S. Young, Bhavisha A. Patel	1
2	Safety and efficacy of immunosuppressive therapy for elderly patients with severe aplastic anaemia 2024 ·British Journal of Haematology ·(unknown), Jibran Durrani, (unknown), Ruba Shalhoub, Jennifer Lotter, Olga Rios, David Ritchie, Colin O. Wu, Bhavisha A. Patel, Neal S. Young, Emma M. Groarke	3
3	Alemtuzumab in relapsed immune severe aplastic anemia: Long‐term results of a phase II study 2023 ·American Journal of Hematology ·(unknown), (unknown), Ruba Shalhoub, Jibran Durrani, Olga Rios, Jennifer Lotter, Bhavisha A. Patel, Colin O. Wu, Neal S. Young, Emma M. Groarke	5
4	Predictors of clonal evolution and myeloid neoplasia following immunosuppressive therapy in severe aplastic anemia 2022 ·Leukemia ·Emma M. Groarke, Bhavisha A. Patel, Ruba Shalhoub, Fernanda Gutierrez‐Rodrigues, Parth Desai, Harshraj Leuva, Yoshitaka Zaimoku, (unknown), (unknown), Jennifer Lotter, Olga Rios, Richard Childs, David J. Young, Alina Dulau‐Florea, Cynthia E. Dunbar, Katherine R. Calvo, Colin O. Wu, Neal S. Young	28
5	Alemtuzumab and Eltrombopag Combination for Patients with Refractory or Relapsed Severe Aplastic Anemia 2022 ·Blood ·(unknown), Jennifer Lotter, Emma M. Groarke, Olga Rios, Neal S. Young, Bhavisha A. Patel	0
6	Eltrombopag added to immunosuppression for children with treatment‐naïve severe aplastic anaemia 2021 ·British Journal of Haematology ·Emma M. Groarke, Bhavisha A. Patel, Fernanda Gutierrez‐Rodrigues, Olga Rios, Jennifer Lotter, Daniela Baldoni, (unknown), Ruba Shalhoub, Colin O. Wu, Danielle M. Townsley, Neal S. Young	36
7	Detectable mutations precede late myeloid neoplasia in aplastic anemia 2020 ·Haematologica ·Bhavisha A. Patel, Jack Ghannam, Emma M. Groarke, Meghali Goswami, Laura W. Dillon, Fernanda Gutierrez‐Rodrigues, Olga Rios, Diego Quinones Raffo, Jennifer Lotter, Neal S. Young, Christopher S. Hourigan	12
8	Circulating exosomal microRNAs in acquired aplastic anemia and myelodysplastic syndromes 2018 ·Haematologica ·Valentina Giudice, (unknown), Fernanda Gutierrez‐Rodrigues, Sachiko Kajigaya, (unknown), Maria del Pilar Fernandez Ibanez, Olga Rios, Christopher K. E. Bleck, Erin Stempinski, Diego Quinones Raffo, Danielle M. Townsley, Neal S. Young	37
9	Circulating S100A8 and S100A9 protein levels in plasma of patients with acquired aplastic anemia and myelodysplastic syndromes 2018 ·Cytokine ·Valentina Giudice, Zhijie Wu, Sachiko Kajigaya, Maria del Pilar Fernandez Ibanez, Olga Rios, Foo Cheung, Sawa Ito, Neal S. Young	33
10	Deep sequencing and flow cytometric characterization of expanded effector memory CD8 ⁺ CD57 ⁺ T cells frequently reveals T-cell receptor Vβ oligoclonality and CDR3 homology in acquired aplastic anemia 2018 ·Haematologica ·Valentina Giudice, Xingmin Feng, (unknown), Wei Hu, Fanmao Zhang, (unknown), Maria del Pilar Fernandez Ibanez, Olga Rios, Neal S. Young	69
11	Aptamer-based proteomics of serum and plasma in acquired aplastic anemia 2018 ·Experimental Hematology ·Valentina Giudice, Angélique Biancotto, Zhijie Wu, Foo Cheung, Julián Candia, Giovanna Fantoni, Sachiko Kajigaya, Olga Rios, Danielle Townsley, Xingmin Feng, Neal S. Young	15
12	Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia breakdown → 2017 ·New England Journal of Medicine ·Danielle M. Townsley, Phillip Scheinberg, Thomas Winkler, Ronan Desmond, Bogdan Dumitriu, Olga Rios, Barbara Weinstein, Janet Valdez, Jennifer Lotter, Xingmin Feng, Marie J. Desierto, Harshraj Leuva, Margaret Bevans, Colin O. Wu, André Larochelle, Katherine R. Calvo, Cynthia E. Dunbar, Neal S. Young	337
13	A plasma microRNA signature as a biomarker for acquired aplastic anemia 2016 ·Haematologica ·Kohei Hosokawa, Sachiko Kajigaya, Xingmin Feng, Marie J. Desierto, Maria del Pilar Fernandez Ibanez, Olga Rios, Barbara Weinstein, Phillip Scheinberg, Danielle M. Townsley, Neal S. Young	34
14	Myeloid Neoplasm Gene Somatic Mutations in Patients with Severe Aplastic Anemia Treated with Eltrombopag and Standard Immunosuppression 2016 ·Blood ·Danielle M. Townsley, James N. Cooper, Thomas Winkler, Phillip Scheinberg, Olga Rios, Barbara Weinstein, Janet Valdez, Jennifer Lotter, Marie J. Desierto, Maria del Pilar Fernandez Ibanez, Colin O. Wu, Cynthia E. Dunbar, Wanlong Ma, Maher Albitar, Neal S. Young	1
15	Alemtuzumab in T-cell large granular lymphocytic leukaemia: interim results from a single-arm, open-label, phase 2 study 2015 ·The Lancet Haematology ·Bogdan Dumitriu, Sawa Ito, Xingmin Feng, Melanie R. Nicol, (unknown), Sachiko Kajigaya, (unknown), Olga Rios, Priscila Scheinberg, (unknown), (unknown), Keyvan Keyvanfar, Minoo Battiwalla, Colin O. Wu, Irina Marić, Liqiang Xi, Mark Raffeld, Pawel Muranski, Danielle M. Townsley, Neal S. Young, Austin John Barrett, (unknown), (unknown)	39
16	Horse antithymocyte globulin as salvage therapy after rabbit antithymocyte globulin for severe aplastic anemia 2014 ·American Journal of Hematology ·Phillip Scheinberg, Danielle Townsley, Bogdan Dumitriu, Priscila Scheinberg, Barbara Weinstein, Olga Rios, Colin O. Wu, Neal S. Young	22
17	Prolonged cyclosporine administration after antithymocyte globulin delays but does not prevent relapse in severe aplastic anemia 2014 ·American Journal of Hematology ·Phillip Scheinberg, Olga Rios, Priscila Scheinberg, Barbara Weinstein, Colin O. Wu, Neal S. Young	33
18	In vivo effects of horse and rabbit antithymocyte globulin in patients with severe aplastic anemia 2014 ·Haematologica ·Xingmin Feng, Phillip Scheinberg, Angélique Biancotto, Olga Rios, Sarah S. Donaldson, Chao‐Liang Wu, Haitao Zheng, Kazuya Sato, Danielle M. Townsley, J. Philip McCoy, Neal S. Young	24
19	Decreased plasma cytokines are associated with low platelet counts in aplastic anemia and immune thrombocytopenic purpura 2012 ·Journal of Thrombosis and Haemostasis ·Xingmin Feng, Phillip Scheinberg, Leigh Samsel, Olga Rios, (unknown), (unknown), Waleed Ghanima, JB Bussel, NS Young	32
20	Different In Vivo Effects of Horse and Rabbit Antithymocyte Globulin in Patients with Severe Aplastic Anemia 2011 ·Blood ·Xingmin Feng, Phillip Scheinberg, Angélique Biancotto, Olga Rios, Sarah S. Donaldson, Colin O. Wu, (unknown), Kazuya Sato, J. Philip McCoy, Neal S. Young	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact